We highlighted genes, including TPX2, MKI67, EXO1, and CTHRC1, as potential biomarkers for early diagnosis, prognostic evaluation, and therapeutic targeting in gastric cancer. This evidence concerns the gene CTHRC1 and gastric cancer.